Global Cannabis Intellectual Property Symposium 2023 session: Ethics: Balancing Activism and Zealous Advocacy with the Boundaries of the Profession and Evolving Law
Global Cannabis Intellectual Property Symposium 2023 session: IP Litigation and Administrative Proceedings: A Global Overview of Managing Cannabis Conflicts
INCBA Global Cannabis Intellectual Property Symposium 2023 session: Cannabis Patents and Plant Variety Rights - Things to Know and Challenges Unique to the Cannabis Industry
This CLE explores whether a mark owner has used its mark to sell improperly labeled soap or an illicit drug, the PTO has no mandate, and no convincing policy reason, to deny the owner the substantial benefits of registration.
Niall will discuss cannabis jurisdiction, legislation, regulation, Medical Cannabis Access Programme (MCAP, the Specified Controlled Drugs (Cannabis-Based Medical Products), indications, CBD - Novel Foods (Conflict of Laws), and adult use in the Republic of Ireland.
Join us for an update - from the comments that INCBA has submitted to the CDFA on behalf of the industry, to the most important aspects of the regulations, and what is necessary to make appellations of origin a functional tool for consumer education and choice in the cannabis industry.